InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Myles David C., Directeur du Développement. Officer active across 1 company, notably Olema Pharmaceuticals, Inc.. Cumulatively, 8 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €700k. History available since 10 December 2021. The latest transaction was disclosed on 12 January 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Myles David C.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
10,000 shares@ US$28.3434.9% of flowCommon StockSEC:0001831216-26-000003:0
1,225 shares@ US$28.086.4% of flowCommon StockSEC:0001831216-25-000004:0
48,750 shares0Common StockSEC:0001415889-24-029027:0
26,250 shares0Common StockSEC:0001415889-23-015458:0
200 shares@ US$17.610.6% of flowCommon StockSEC:0001415889-23-015041:0
6,668 shares@ US$15.0218.3% of flowCommon StockSEC:0001415889-23-014792:0
20,000 shares@ US$12.6746.1% of flowCommon StockSEC:0001415889-23-013474:0
10,000 shares@ US$10.3013.0% of flowCommon StockSEC:0001415889-21-005860:0
8 of 8 declarations
About Myles David C.
Myles David C. is Directeur du Développement and also holds the role of CH. DISCOV. & NON-CLIN DEV OFF at Olema Pharmaceuticals, Inc. on XNAS. He has 8 filings in total, and across the 8 sampled filings between 2021-12-14 and 2026-01-14, the modal transaction nature is Sell, with total sales of EUR 699536 and no purchases.
